# Trade Mark Journal No.2026/009 27 February 2026

## WO0000001888711 (9,42)

Office of origin: United States of America

Date of International Registration:17 June 2025
Date of designation in the UK: 17 June 2025

International priority date claimed: 17 December 2024 (United States of America) (98908197)

Class 9
  Downloadable mobile software application for clinical trial data collection and management; software enabling clinical trial participants and research staff to submit health metrics, biospecimen data, survey responses, and treatment adherence information from mobile devices; software providing secure, encrypted data transfer compliant with regulatory standards; software featuring data validation and monitoring, participant engagement tools such as notifications and reminders, and integration with electronic data capture (EDC) and laboratory information management systems (LIMS).
Class 42
  Software as a service (SaaS) featuring a mobile platform for capturing, managing, and analyzing participant data in clinical trials; providing temporary use of non-downloadable cloud-based software enabling clinical trial participants to input health metrics, complete digital surveys, and track treatment adherence; SaaS services offering tools for data collection, remote monitoring, data validation, and secure data management accessible to research teams through secure cloud-based infrastructure; Software as a Service (SaaS) featuring software for ensuring compliance with regulatory standards including 21 CFR Part 11, featuring encryption, authentication, and access control; providing temporary use of online, non-downloadable software featuring user engagement tools such as reminders, notifications, and messaging systems to promote participant adherence and engagement; Software as a Service (SaaS) featuring software that enables integration services with electronic data capture (EDC), laboratory information management systems (LIMS), and clinical trial management systems for streamlined clinical data management.

TruLab, Inc.

Representative: Mewburn Ellis LLP, Aurora Building, Counterslip Bristol BS1 6BX UNITED KINGDOM